ADGRL4 and cancer: Past comprehensive signalling screens have concluded that ADGRL4 does not couple to G proteins38,46, whilst studies in cancer cell lines have shown it to activate downstream components of the JAK/STAT323 and MAPK/ERK26,37 pathways; both pathways can be triggered via multiple mechanisms, including G protein coupling.